Walsh, D. J., Rees, J. R., Mehra, S., Bourkas, M. E. C., Kaczmarczyk, L., Stuart, E., . . . Supattapone, S. (2024). Anti-prion drugs do not improve survival in novel knock-in models of inherited prion disease. PLoS Pathogens, 20(4), 1. https://doi.org/10.1371/journal.ppat.1012087
Chicago Style (17th ed.) CitationWalsh, Daniel J., Judy R. Rees, Surabhi Mehra, Matthew E. C. Bourkas, Lech Kaczmarczyk, Erica Stuart, Walker S. Jackson, Joel C. Watts, and Surachai Supattapone. "Anti-prion Drugs Do Not Improve Survival in Novel Knock-in Models of Inherited Prion Disease." PLoS Pathogens 20, no. 4 (2024): 1. https://doi.org/10.1371/journal.ppat.1012087.
MLA (9th ed.) CitationWalsh, Daniel J., et al. "Anti-prion Drugs Do Not Improve Survival in Novel Knock-in Models of Inherited Prion Disease." PLoS Pathogens, vol. 20, no. 4, 2024, p. 1, https://doi.org/10.1371/journal.ppat.1012087.